Marlen SÜLEYMAN, Can ERSAK, Fatih KARAAHMET, Abdullah DURHAN, İlknur ALKAN KUŞABBİ, Mehmet ŞENES, Mesut TEZ, Eylem Pınar ESER, Sema HÜCÜMENOĞLU, Koray KOŞMAZ, Abdullah ŞENLİKCİ, Recep PEKÇİCİ, Yılmaz ÜNAL

Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury

Background/aim: To investigate possible protective effects of Ankaferd Blood Stopper® (ABS) in an experimental liver ischemia reperfusion injury (IRI) model. Materials and methods: The study was carried out on 30 female rats separated into 3 groups as sham, control (IRI), and treatment (IRI + ABS) groups. In the IRI + ABS group, 0.5 mL/day ABS was given for 7 days before surgery. In the IRI and IRI + ABS groups, the hepatic pedicle was clamped for 30 min to apply ischemia. Then, after opening the clamp, 90-min reperfusion of the liver was provided. Blood and liver tissue samples were taken for biochemical and histopathological analyses. Results: Compared to the sham group, the IRI group had significantly higher levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total oxidant status (TOS), malondialdehyde (MDA), fluorescent oxidant products (FOP) and lower expression of albumin and total antioxidant status (TAS) (P < 0.05). Compared to the IRI group, the IRI+ABS group showed lower expression of AST, ALT, TOS, MDA and FOP and higher expression of albumin and TAS (P < 0.05). In the histopathological analysis, congestion scores were statistically significantly lower in the IRI + ABS group than in the IRI group. Conclusions: ABS has a strong hepatoprotective effect due to its antioxidant and antiinflammatory effects and could therefore be used as a potential therapeutic agent for IRI. Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Cerrahi Onkoloji Anabilim Dalı, Ankara, Türkiye 2Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Bölümü, Gastrointestinal Cerrahi Anabilim Dalı, Ankara, Türkiye Sağlık Bakanlığı, Ankara Eğitim ve Araştırma Hastanesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye

PDF

___

1. Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL et al. Current mechanistic concepts in ischemia and reperfusion injury. Cellular Physiology and Biochemistry 2018; 46 (4): 1650-1667. doi: 10.1159/000489241
2. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. Journal of Investigative Surgery 2005; 18 (6): 335-350. doi: 10.1080/08941930500328862
3. Ornellas FM, Ornellas DS, Martini SV, Castiglione RC, Ventura GM et al. Bone marrow-derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory, antioxidant and apoptotic related molecules. Cellular Physiology and Biochemistry 2017; 41 (5): 1736-1752. doi: 10.1159/000471866
4. Ling Q, Yu X, Wang T, Wang SG, Ye ZQ et al. Roles of the exogenous H2S-mediated SR-A signaling pathway in renal ischemia/ reperfusion injury in regulating endoplasmic reticulum stress-induced autophagy in a rat model. Cellular Physiology and Biochemistry 2017; 41 (6): 2461-2474. doi: 10.1159/000475915
5. Guan LY, Fu PY, Li PD, Li ZN, Liu HY et al. Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide. World Journal of Gastrointestinal Surgery 2014; 6 (7): 122-128. doi: 10.4240/wjgs.v6.i7.122
6. Cannistra M, Ruggiero M, Zullo A, Gallelli G, Serafini S et al. Hepatic ischemia reperfusion injury: a systematic review of literature and the role of current drugs and biomarkers. International Journal of Surgery 2016; 33 (Suppl 1): S57-70. doi: 10.1016/j.ijsu
7. Huguet C, Addario-Chieco P, Gavelli A, Arrigo E, Harb J et al. Technique of hepatic vascular exclusion for extensive liver resection. American Journal of Surgery 1992; 163 (6): 602-605. doi: 10.1016/0002-9610(92)90567-b
8. Jiang X, Kuang G, Gong X, Jiang R, Xie T et al. Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice. International Immunopharmacology 2019; 76: 105870. doi: 10.1016/j. intimp.2019.105870
9. Ünal Y, Küçük B, Tuncal S, Koşmaz K, Çavuşoğlu NT et al. Assessment of the effect of calcium dobesilate in experimental liver ischemia-reperfusion injury. Ulus Travma Acil Cerrahi Dergisi 2018; 24 (5): 391-397. doi: 10.5505/tjtes.2018.33238
10. Park HK, Kang SW, Park MS. Hesperidin ameliorates hepatic ischemia-reperfusion injury in Sprague-Dawley rats. Transplantation Proceedings 2019; 51 (8): 2828‐2832. doi: 10.1016/j.transproceed.2019.02.059
11. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. The Journal of International Medical Research 2008; 36 (1): 163-170. doi: 10.1177/147323000803600121
12. Uğur A, Saraç N, Çankal DA, Özle M. The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry. Turkish Journal of Medical Sciences 2016; 46 (3): 657-663. doi: 10.3906/sag-1504-62
13. Koçak E, Akbal E, Taş A, Köklü S, Karaca G et al. Antiinflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi Journal of Gastroenterology 2013; 19 (3): 126-130. doi: 10.4103/1319- 3767.111955
14. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55 (6): 1265-1272. doi: 10.1097/00007890-199306000-00011
15. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clinical Chemistry 1993; 39 (12): 2522-2526. doi: 10.1093/clinchem/39.12.2522
16. Wu T, Willett WC, Rifai N, Rimm EB. Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. American Journal of Epidemiology 2007; 166 (5): 552-560. doi: 10.1093/aje/kwm119
17. Nastos C, Kalimeris K, Papoutsidakis N, Tasoulis MK, Lykoudis PM et al. Global consequences of liver ischemia/reperfusion injury. Oxidative Medicine and Cellular Longevity 2014; 2014: 906965. doi: 10.1155/2014/906965
18. Weigand K, Brost S, Steinebrunner N, Buchler M, Schemmer P et al. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. Hepatic Pancreatic and Biliary Surgery 2012; 2012: 176723. doi: 10.1155/2012/176723
19. Yamanaka K, Houben P, Bruns H, Schultze D, Hatano E et al. A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation. Public Library of Science One 2015; 10 (4): e0122214. doi: 10.1371/journal.pone.0122214
20. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clinical and Applied Thrombosis Hemostasis 2010; 16 (4): 446-453. doi: 10.1177/1076029609343706
21. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Alternative Medicine Review 2010; 15 (4): 329-336.
22. Ciftciler R, Ciftciler AE, Malkan UY, Haznedaroglu IC. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper). SAGE Open Medicine 2020; 8. doi: 10.1177/2050312120907811
23. Salehi B, Mishra AP, Shukla I, Sharifi-Rad M, Contreras MDM et al. Thymol, thyme, and other plant sources: health and potential uses. Phytotherapy Research 2018; 32 (9): 1688-1706. doi: 10.1002/ptr.6109
24. Youdim KA, Deans SG. Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid composition of the ageing rat brain. British Journal of Nutrition 2000; 83 (1): 87-93. doi: 10.1017/S000711450000012X
25. Liang D, Li F, Fu Y, Cao Y, Song X et al. Thymol inhibits LPSstimulated inflammatory response via down-regulation of NF- κB and MAPK signaling pathways in mouse mammary epithelial cells. Inflammation 2014; 37 (1): 214-222. doi: 10.1007/s10753-013-9732-x
26. Fachini-Queiroz FC, Kummer R, Estevao-Silva CF, Carvalho MD, Cunha JM et al. Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evidence-Based Complementary and Alternative Medicine 2012; 2012. doi: 10.1155/2012/657026
27. Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira M. Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review. Phytotherapy Research 2018; 32 (12): 2323-2339. doi: 10.1002/ptr.6178
28. Nassiri-Asl M, Hosseinzadeh H. Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive constituents: an update. Phytotherapy Research 2016; 30 (9): 1392-1403. doi: 10.1002/ptr.5644
29. Honmore VS, Kandhare AD, Kadam PP, Khedkar VM, Sarkar D et al. Isolates of Alpinia officinarum Hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies. International Immunopharmacology 2016; 33: 8-17. doi: 10.1016/j.intimp.2016.01.024
30. Carvalho AR, Costa G, Figueirinha A, Liberal J, Prior JAV et al. Urtica spp.: phenolic composition, safety, antioxidant and antiinflammatory activities. Food Research International 2017; 99 (Pt 1): 485-494. doi: 10.1016/j.foodres.2017.06.008
31. Hasgul R, Uysal S, Haltas H, Akyol S, Yuksel Y et al. Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury. Toxicology and Industrial Health 2014; 30 (10): 888-895. doi: 10.1177/0748233712466134